GlobeNewswire - News from Israel

Playtika Announces Pricing of $600 Million of Senior Notes Due 2029

Fri, 05 Mar 2021 20:49 GMT

HERZLIYA, Israel, March 05, 2021 (GLOBE NEWSWIRE) -- Playtika Holding Corp. (NASDAQ:PLTK) (“Playtika”) today announced that it successfully priced its previously announced offering of $600 million aggregate principal amount of its senior notes due 2029 at par. The notes will bear interest at a fixed rate of 4.250% per year and will mature on March 15, 2029. The offering is expected to close March 11, 2021, subject to customary closing conditions.

Weebit Nano to Attend 33rd Annual ROTH Growth Conference

Thu, 04 Mar 2021 17:00 GMT

HOD HASHARON, Israel, March 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Weebit Nano Ltd (ASX:WBT), a leading developer of next-generation semiconductor memory technology, announced that its CEO Coby Hanoch will attend the 33^rd Annual ROTH Growth Conference being held virtually March 15 - 17, 2021. The ROTH Conference will feature presentations from public and private companies across a variety of industry sectors. During previous events, ROTH has hosted close to 550 participating companies and attracted more than 5,000 attendees, including institutional investors, analysts, family offices and high-net-worth investors.

RADA Announces Pricing of Public Offering of 4,500,000 Ordinary Shares

Thu, 04 Mar 2021 13:39 GMT

NETANYA, Israel, March 04, 2021 (GLOBE NEWSWIRE) -- RADA Electronic Industries Ltd.?(“RADA”) (NASDAQ and TASE: RADA),?a global defense technology company, today announced the pricing of its public offering of 4,500,000 ordinary shares at a public offering price of $11.50 per share. The gross proceeds to RADA from this offering are expected to be approximately $51.75 million before deducting the underwriting discounts and commissions and other offering expenses payable by RADA.

MIND CTI Reports Fourth Quarter and Full Year 2020 Results

Thu, 04 Mar 2021 13:39 GMT

*Board Declares Cash Dividend
* MIND CTI to Host Annual Meeting of Shareholders

Entera Bio To Present At The H.C. Wainwright Global Life Sciences Conference

Thu, 04 Mar 2021 13:30 GMT

BOSTON and JERUSALEM, March 04, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its management team will participate in the H.C. Wainwright Global Life Sciences Conference. As part of the virtual conference, which is being held March 9-10, 2021, Spiros Jamas, Entera’s Chief Executive Officer will present an overview of the Company's business.

Creazioni Digitali Implements Kornit Presto S with Softener Solution for Versatile, High-Capacity Fashion Production on Demand

Thu, 04 Mar 2021 13:30 GMT

Como-based fabric provider to high-end fashion houses cites sustainability, single-step process in adopting new direct-to-fabric print technology

Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update

Thu, 04 Mar 2021 12:05 GMT

? Epsolay^?and Twyneo^?PDUFA goal dates set for April 26, 2021 and August 1, 2021 respectively

VBL Therapeutics Announces Peer-reviewed Publication of Positive Results of Pre-specified Interim Analysis of OVAL, a Phase 3 Registration Enabling Study of VB-111 in Ovarian Cancer

Thu, 04 Mar 2021 12:00 GMT

TEL AVIV, Israel, March 04, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced the online publication of positive results of the pre-specified interim analysis of the OVAL study, a Phase 3 registration enabling study of VB-111 (ofranergene obadenovec) in recurrent platinum-resistant ovarian cancer. The analysis showed a CA-125 GCIG response rate of 58% or higher in evaluable patients in the VB-111 treatment arm. Based on the results of the interim analysis, the Data and Safety Monitoring Committee (DSMC) recommended continuing the trial as planned. The results were published online in the international peer reviewed journal Gynecologic Oncology (https://doi.org/10.1016/j.ygyno.2021.02.014).

RADA Announces Proposed Public Offering of Ordinary Shares

Wed, 03 Mar 2021 21:01 GMT

NETANYA, Israel, March 03, 2021 (GLOBE NEWSWIRE) -- RADA Electronic Industries Ltd.?(“RADA”) (NASDAQ and TASE: RADA),?a global defense technology company, today announced that it intends to offer and sell its ordinary shares in an underwritten public offering. RADA also expects to grant to the underwriters a 30-day option to purchase up to an additional 15% of its ordinary shares sold in the offering on the same terms and conditions.? There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering.

Gilat's In-Flight Connectivity High-Power Transceiver Successfully Tested by Global Eagle Entertainment for DO-160G Certification

Wed, 03 Mar 2021 12:08 GMT

Production units are planned to be shipped for usage in commercial aircraft, starting in the second quarter of 2021

Production units are planned to be shipped for usage in commercial aircraft, starting in the second quarter of 2021

Roll-to-Roll Continuous Inkjet Printed Electronics Demonstrated with PV Nano Cell’s Sicrys? Conductive Ink

Wed, 03 Mar 2021 12:07 GMT

MIGDAL HA’EMEK, Israel, March 03, 2021 (GLOBE NEWSWIRE) -- PV Nano Cell Ltd. (OTC:?PVNNF), (the “Company”), an innovative provider of inkjet-based conductive digital printing solutions and producer of conductive digital inks, today announced that its Sicrys??conductive ink was successfully used in Roll-to-Roll (R2R) continues inkjet printing of electronics as part of the DigiMan project. PV Nano Cell project partners were: C.P.C Solutions Ltd., Fraunhofer IKTS and Fraunhofer ENAS, Kerafol Keramische Folien GmbH & Co. KG, RIIT Ltd. OSTEC Group, Technical University of Chemnitz and MEPhI.

Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors

Wed, 03 Mar 2021 12:00 GMT

Rehovot, Israel, March 03, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance, today announced the appointment of Robert Gagnon to its Board of Directors. Mr. Gagnon has 15 years of experience in corporate finance and commercial operations, much of it in the biotech industry. Purple Biotech’s Board of Directors now includes seven members, five of whom are independent directors. Mr. Gagnon shall serve as a member of the first class of the Board of Directors until the annual general meeting of shareholders to be held in 2022, at which time he may stand for reelection.

Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in the U.S.

Wed, 03 Mar 2021 12:00 GMT

Transaction Furthers Kamada’s Strategic Objective to Evolve into a Fully Integrated Specialty Plasma Company

Playtika Announces Proposed Offering of $600 Million of Senior Notes Due 2029

Tue, 02 Mar 2021 21:07 GMT

HERZLIYA, Israel, March 02, 2021 (GLOBE NEWSWIRE) -- Playtika Holding Corp. (NASDAQ:PLTK)?(“Playtika”) today announced that it intends to offer, subject to market conditions and other factors, $600 million aggregate principal amount of its senior notes due 2029.

Nanox Announces Fourth Quarter 2020 Results and Provides Business Update

Tue, 02 Mar 2021 13:00 GMT

Successfully demonstrates the Nanox.ARC in range of 2D and 3D imaging applications at the 2020 Radiology Society of North America (RSNA) Virtual Annual Meeting

Purple Biotech Provides Corporate Update and Reports Second Half and Full Year 2020 Financial Results

Tue, 02 Mar 2021 12:00 GMT

Rehovot, Israel, March 02, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance, today provided a corporate update and announced financial results for the six and 12-months ended December 31, 2020.

InspireMD to Report Fourth Quarter and Year-End 2020 Financial Results on Tuesday, March 9, 2021 and Provide Corporate Update

Tue, 02 Mar 2021 11:00 GMT

Earnings conference call to be held Tuesday, March 9, 2021 at 8:30 a.m. ET

Earnings conference call to be held Tuesday, March 9, 2021 at 8:30 a.m. ET

Itamar Medical Reports Record Fourth Quarter and Full Year 2020 Revenues

Tue, 02 Mar 2021 11:00 GMT

- Record Fourth Quarter 2020 Revenues Increase 31% to $12.8 Million -?

Exetel Launches Anti-malware and Parental Control Services, Powered by Allot NetworkSecure

Tue, 02 Mar 2021 09:04 GMT

Australian consumers will be protected by a premium cybersecurity service

Australian consumers will be protected by a premium cybersecurity service

NeoGames Announces Fourth Quarter and Year-End 2020 Earnings Release Date

Mon, 01 Mar 2021 21:15 GMT

LUXEMBOURG, March 01, 2021 (GLOBE NEWSWIRE) -- NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the "Company"), a technology-driven provider of end-to-end iLottery solutions, announced today that it will release its fourth quarter and year-end 2020 results after the market closes on Wednesday, March 10, 2021.